Haverford Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.3M | Sell |
80,847
-912
| -1% | -$196K | 0.18% | 84 |
|
|
2026
Q1 | $17.8M | Sell |
81,759
-1,035
| -1% | -$230K | 0.16% | 87 |
|
|
2025
Q4 | $18.9M | Sell |
82,794
-637
| -0.8% | -$145K | 0.17% | 84 |
|
|
2025
Q3 | $19.3M | Sell |
83,431
-11,678
| -12% | -$2.38M | 0.17% | 82 |
|
|
2025
Q2 | $17.7M | Sell |
95,109
-396
| -0.4% | -$73.6K | 0.17% | 86 |
|
|
2025
Q1 | $20M | Sell |
95,505
-150
| -0.2% | -$29.2K | 0.2% | 79 |
|
|
2024
Q4 | $17M | Buy |
95,655
+346
| +0.4% | +$63.6K | 0.17% | 83 |
|
|
2024
Q3 | $18.8M | Buy |
95,309
+237
| +0.2% | +$44.2K | 0.18% | 79 |
|
|
2024
Q2 | $16.3M | Sell |
95,072
-3,374
| -3% | -$559K | 0.17% | 80 |
|
|
2024
Q1 | $17.9M | Buy |
98,446
+3,503
| +4% | +$604K | 0.19% | 79 |
|
|
2023
Q4 | $14.7M | Buy |
94,943
+3,093
| +3% | +$451K | 0.16% | 83 |
|
|
2023
Q3 | $13.7M | Sell |
91,850
-1,632
| -2% | -$240K | 0.17% | 82 |
|
|
2023
Q2 | $12.6M | Buy |
93,482
+616
| +0.7% | +$90.3K | 0.14% | 83 |
|
|
2023
Q1 | $14.8M | Buy |
92,866
+1,550
| +2% | +$237K | 0.18% | 79 |
|
|
2022
Q4 | $14.8M | Buy |
91,316
+288
| +0.3% | +$44.2K | 0.18% | 74 |
|
|
2022
Q3 | $12.2M | Sell |
91,028
-5,305
| -6% | -$761K | 0.17% | 80 |
|
|
2022
Q2 | $14.8M | Sell |
96,333
-3,420
| -3% | -$523K | 0.19% | 74 |
|
|
2022
Q1 | $16.2M | Buy |
99,753
+133
| +0.1% | +$19.3K | 0.19% | 75 |
|
|
2021
Q4 | $13.5M | Buy |
99,620
+591
| +0.6% | +$69.8K | 0.15% | 78 |
|
|
2021
Q3 | $10.7M | Buy |
99,029
+5,241
| +6% | +$599K | 0.13% | 85 |
|
|
2021
Q2 | $10.6M | Sell |
93,788
-7,870
| -8% | -$886K | 0.12% | 87 |
|
|
2021
Q1 | $11M | Buy |
101,658
+1,500
| +1% | +$160K | 0.14% | 79 |
|
|
2020
Q4 | $10.7M | Buy |
100,158
+8,152
| +9% | +$783K | 0.15% | 71 |
|
|
2020
Q3 | $8.06M | Buy |
92,006
+5,195
| +6% | +$489K | 0.13% | 75 |
|
|
2020
Q2 | $8.52M | Buy |
86,811
+4,133
| +5% | +$364K | 0.15% | 71 |
|
|
2020
Q1 | $6.3M | Sell |
82,678
-951
| -1% | -$81K | 0.13% | 76 |
|
|
2019
Q4 | $7.41M | Sell |
83,629
-1,470
| -2% | -$122K | 0.12% | 85 |
|
|
2019
Q3 | $6.44M | Sell |
85,099
-189
| -0.2% | -$13K | 0.11% | 85 |
|
|
2019
Q2 | $6.2M | Sell |
85,288
-1,795
| -2% | -$141K | 0.11% | 85 |
|
|
2019
Q1 | $7.02M | Sell |
87,083
-3,636
| -4% | -$297K | 0.13% | 83 |
|
|
2018
Q4 | $8.36M | Buy |
90,719
+654
| +0.7% | +$57.5K | 0.18% | 74 |
|
|
2018
Q3 | $8.52M | Buy |
90,065
+392
| +0.4% | +$37.2K | 0.16% | 76 |
|
|
2018
Q2 | $8.31M | Sell |
89,673
-884
| -1% | -$86.3K | 0.16% | 76 |
|
|
2018
Q1 | $8.57M | Sell |
90,557
-1,429
| -2% | -$157K | 0.17% | 73 |
|
|
2017
Q4 | $8.9M | Buy |
91,986
+1,085
| +1% | +$102K | 0.17% | 72 |
|
|
2017
Q3 | $8.08M | Sell |
90,901
-544
| -0.6% | -$41.4K | 0.17% | 69 |
|
|
2017
Q2 | $6.63M | Buy |
91,445
+2,316
| +3% | +$156K | 0.14% | 71 |
|
|
2017
Q1 | $5.81M | Sell |
89,129
-1,194
| -1% | -$75.1K | 0.13% | 70 |
|
|
2016
Q4 | $5.66M | Buy |
90,323
+721
| +0.8% | +$44K | 0.14% | 71 |
|
|
2016
Q3 | $5.65M | Sell |
89,602
-142
| -0.2% | -$9.19K | 0.14% | 70 |
|
|
2016
Q2 | $5.56M | Buy |
89,744
+1,767
| +2% | +$108K | 0.14% | 74 |
|
|
2016
Q1 | $5.03M | Sell |
87,977
-2,841
| -3% | -$158K | 0.13% | 72 |
|
|
2015
Q4 | $5.38M | Sell |
90,818
-675
| -0.7% | -$38.9K | 0.14% | 72 |
|
|
2015
Q3 | $4.83M | Buy |
91,493
+17,122
| +23% | +$1.11M | 0.14% | 68 |
|
|
2015
Q2 | $5M | Sell |
74,371
-927
| -1% | -$60.5K | 0.14% | 69 |
|
|
2015
Q1 | $4.41M | Buy |
75,298
+4,378
| +6% | +$264K | 0.12% | 75 |
|
|
2014
Q4 | $4.64M | Sell |
70,920
-321
| -0.5% | -$20.2K | 0.13% | 77 |
|
|
2014
Q3 | $4.12M | Buy |
71,241
+2,251
| +3% | +$125K | 0.12% | 76 |
|
|
2014
Q2 | $3.89M | Buy |
68,990
+37
| +0.1% | +$1.94K | 0.11% | 75 |
|
|
2014
Q1 | $3.54M | Sell |
68,953
-102,268
| -60% | -$5.17M | 0.11% | 75 |
|
|
2013
Q4 | $9.04M | Buy |
171,221
+7,732
| +5% | +$380K | 0.25% | 67 |
|
|
2013
Q3 | $7.31M | Buy |
163,489
+2,375
| +1% | +$105K | 0.27% | 56 |
|
|
2013
Q2 | $6.66M | Buy |
+161,114
| New | +$7.05M | 0.22% | 68 |
|
Other funds holding ABBV
Haverford Trust Company's ABBV Position: Q2 2026 in Review
Haverford Trust Company reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $196K and leaving 80,847 shares worth $20.3M. The position accounts for 0.18% of the portfolio, ranked #84.
Haverford Trust Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Haverford Trust Company held 80,847 shares of AbbVie worth $20.3M as of Q2 2026.
- Haverford Trust Company sold 912 AbbVie shares in Q2 2026, an estimated $196K.
- AbbVie made up 0.18% of Haverford Trust Company's portfolio in Q2 2026, its #84 holding.
- Haverford Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.